The principal goal of the Division of Nephrology is to excel in research, education and patient care related to diverse kidney disease. The current brochure illustrates the list of faculty members and their clinical, research and educational activities including publications and sponsored research performed during the past three years. The Division's vision for the next five years has also been stated in this brochure.
Kevin R. Regner, MD, in collaboration with Scott Van Why, MD (Pediatric Nephrology), is establishing a research laboratory that will focus on ischemic acute kidney injury (AKI).
Eric Cohen, MD, John Moulder, PhD (Radiation Biology, MCW), and John Imig, PhD (Pharmacology, MCW) continue their focused research investigation in the pathogenesis and therapy of radiation nephropathy.
The laboratory of Andrey Sorokin, PhD, is interested in multiple projects with focus on cell signaling as related to pathobiology of kidney disease.
Samuel S. Blumenthal, MD, is interested in the role of the kidney in hypertension and the mechanisms underlying hypertension and diabetic nephropathy.
Samuel Blumenthal, MD, Barbara Bresnahan, MD, Hariprasad Trivedi, MD, and Walter Piering, MD, are primarily involved in several areas of ongoing clinical research activity in subjects with CKD and ESRD.
Barbara Bresnahan, MD, Brahm Vasudev, MD, and Ehab R. Saad, MD, have been involved in a number of pharmaceutical and NIH-sponsored clinical studies in the kidney transplant field.
The kidney stone research group at MCW conducts peer reviewed funded studies on a number of critical aspects on the pathophysiologic mechanisms mediating the initiation and progression of urinary tract kidney stone disease.